Innovating Works
SUCZYME: VALORISATION AND OPTIMIZATION OF NOVEL FIRST-IN CLASS SUCCINATE-DEPLETING THERAPIES SUCCIPRO SL tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02 SUCCIPRO is a spin-off company from Pere Virgili Health Institute and Rovira Virgili University. It is an early-stage drug development comp...
2023-06-01 - 2024-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.